Advertisement
Natera, Inc.

Natera, Inc. (NTRA) Stock Overview

Explore Natera, Inc.โ€™s financial performance, market position, analyst ratings, and future outlook.

NTRAโ—NASDAQ
HealthcareMedical - Diagnostics & Research
$265.87
$5.90(2.27%)
U.S. Market is Open ยท 11:10
Advertisement

Natera, Inc. (NTRA)

Meyka AI Score

Z

Key Financials

Market Cap37.3B
P/E Ratio-160.39
EPS (TTM)$-1.59
ROE-0.15%
Fundamental Analysis

AI Price Forecasts

1 Month$224.13
3 Months$229.46
1 Year Target$217.74

NTRA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Natera, Inc. (NTRA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 73.16, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $217.74.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -160.39 and a market capitalization of 37.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.30%
5-Day Change
12.62%
1-Month Change
29.78%
3-Month Change
32.11%
6-Month Change
11.55%
Year-to-Date (YTD) Change
13.82%
1-Year Change
58.83%
3-Year Change
423.05%
5-Year Change
126.44%
All-Time (Max) Change
1348.56%

Contact Information

650 249 9090
13011 McCallen Pass Building A, Austin, CA, 78753

Company Facts

44,240 Employees
IPO DateJul 1, 2015
CountryUS
Actively Trading

Frequently Asked Questions